Mesenchymal stem cells administered after liver transplantation prevent acute graft-versus-host disease in rats

Liver Transplantation

Volumn 18, Issue 6, 2012, Pages 696-706

  Xia, Xuefeng ^a   Chen, Wei ^a   Ma, Tao ^a   Xu, Guodong ^b   Liu, Hao ^a   Liang, Chao ^a   Bai, Xueli ^a   Zhang, Yun ^a   He, Yong ^c   Liang, Tingbo ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Lihuili Hospital of Ningbo Medical Center   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTESTINE; LIVER TRANSPLANTATION; MALE; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY T LYMPHOCYTE; SURVIVAL TIME;

ACUTE DISEASE; ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRAFT VS HOST DISEASE; IMMUNOPHENOTYPING; INTESTINES; LIVER TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; POSTOPERATIVE COMPLICATIONS; RATS; RATS, INBRED BN; RATS, INBRED LEW; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; T-LYMPHOCYTES, REGULATORY;

EID: 84861811350     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23414     Document Type: Article

References (39)

1. Burdick JF, Vogelsang GB, Smith WJ, Farmer ER, Bias WB, Kaufmann SH, et al. Severe graft-versus-host disease in a liver-transplant recipient. N Engl J Med 1988; 318: 689-691.
2. Smith DM, Agura E, Netto G, Collins R, Levy M, Goldstein R, et al. Liver transplant-associated graft-versus-host disease. Transplantation 2003; 75: 118-126.
3. Taylor AL, Gibbs P, Bradley JA,. Acute graft versus host disease following liver transplantation: the enemy within. Am J Transplant 2004; 4: 466-474.
4. Kuball J, Theobald M, Ferreira EA, Hess G, Burg J, Maccagno G, et al. Control of organ transplant-associated graft-versus-host disease by activated host lymphocyte infusions. Transplantation 2004; 78: 1774-1779.
5. Soejima Y, Shimada M, Suehiro T, Hiroshige S, Gondo H, Takami A, et al. Graft-versus-host disease following living donor liver transplantation. Liver Transpl 2004; 10: 460-464.
6. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 1127-1152.
7. Sudhindran S, Taylor A, Delriviere L, Collins VP, Liu L, Taylor CJ, et al. Treatment of graft-versus-host disease after liver transplantation with basiliximab followed by bowel resection. Am J Transplant 2003; 3: 1024-1029.
8. Friedenstein AJ, Gorskaja JF, Kulagina NN,. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4: 267-274.
9. Prockop DJ,. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-74.
10. Caplan AI,. Mesenchymal stem cells. J Orthop Res 1991; 9: 641-650.
11. Noort WA, Kruisselbrink AB, in't Anker PS, Kruger M, van Bezooijen RL, de Paus RA, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2002; 30: 870-878.
12. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-3843.
13. Ozawa K, Sato K, Oh I, Ozaki K, Uchibori R, Obara Y, et al. Cell and gene therapy using mesenchymal stem cells (MSCs). J Autoimmun 2008; 30: 121-127.
14. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, Dazzi F,. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722-3729.
15. Klyushnenkova E, Mosca JD, Zernetkina V, Majumdar MK, Beggs KJ, Simonetti DW, et al. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci 2005; 12: 47-57.
16. Devine SM, Bartholomew AM, Mahmud N, Nelson M, Patil S, Hardy W, et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 2001; 29: 244-255.
17. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, Ringdén O,. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-1441.
18. Dazzi F, Marelli-Berg FM,. Mesenchymal stem cells for graft-versus-host disease: close encounters with T cells. Eur J Immunol 2008; 38: 1479-1482.
19. Xue F, Chen W, Wang XG, Liang L, Bai XL, Wang LY, et al. Establishment of an acute graft-versus-host disease model following liver transplantation in donor-dominant one-way major histocompatibility complex matching rats. Transplant Proc 2009; 41: 1914-1920.
20. Kamada N, Calne RY,. A surgical experience with five hundred thirty liver transplants in the rat. Surgery 1983; 93 (pt 1): 64-69.
21. Foudah D, Redaelli S, Donzelli E, Bentivegna A, Miloso M, Dalprà L, Tredici G,. Monitoring the genomic stability of in vitro cultured rat bone-marrow-derived mesenchymal stem cells. Chromosome Res 2009; 17: 1025-1039.
22. Inoue S, Popp FC, Koehl GE, Piso P, Schlitt HJ, Geissler EK, Dahlke MH,. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 2006; 81: 1589-1595.
23. Chung NG, Jeong DC, Park SJ, Choi BO, Cho B, Kim HK, et al. Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation. Int J Hematol 2004; 80: 370-376.
24. Xue F, Chen W, Wang X, Wang L, Xu G, Liang L, et al. Regulatory T cells contribute to the immunoregulatory effect on graft versus host reaction after liver transplantation in donor-dominant one-way MHC matching rats. Transpl Immunol 2009; 20: 232-237.
25. + T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 2005; 90: 516-525.
26. Aggarwal S, Pittenger MF,. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-1822.
27. + regulatory T cells. Stem Cells 2008; 26: 212-222.
28. Casiraghi F, Azzollini N, Cassis P, Imberti B, Morigi M, Cugini D, et al. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 2008; 181: 3933-3946.
29. + regulatory T cells. Clin Exp Immunol 2009; 156: 149-160.
30. + T cells. J Immunol 2005; 175: 1483-1490.
31. Sakaguchi S, Yamaguchi T, Nomura T, Ono M,. Regulatory T cells and immune tolerance. Cell 2008; 133: 775-787.
32. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringdén O,. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003; 57: 11-20.
33. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003; 102: 3837-3844.
34. Kim SW, Han H, Chae GT, Lee SH, Bo S, Yoon JH, et al. Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells 2006; 24: 1620-1626.
35. Kim D, Chun BG, Kim YK, Lee YH, Park CS, Jeon I, et al. In vivo tracking of human mesenchymal stem cells in experimental stroke. Cell Transplant 2008; 16: 1007-1012.
36. Ringdén O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lönnies H, et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006; 81: 1390-1397.
37. Zhou HP, Yi DH, Yu SQ, Sun GC, Cui Q, Zhu HL, et al. Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft. Transplant Proc 2006; 38: 3046-3051.
38. Aksu AE, Horibe E, Sacks J, Ikeguchi R, Breitinger J, Scozio M, et al. Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats. Clin Immunol 2008; 127: 348-358.
39. Dahlke MH, Hoogduijn M, Eggenhofer E, Popp FC, Renner P, Slowik P, et al.; for MISOT Study Group. Toward MSC in solid organ transplantation: 2008 position paper of the MISOT study group. Transplantation 2009; 88: 614-619.